Drug prices may reduce in Kazakhstan
Prices for medicines may go down Kazakh Minister of Health and Social Development Tamara Duissenova said at the plenary session of Majilis. MPs ratified the agreement with Armenia allowing their pharmaceutical manufacturers to import medicine to Kazakhstan on facilitated conditions – this could trigger a drop in prices. According to the ministry, this agreement will also benefit Kazakhstan’s pharmaceutical companies.
Tamara DUISSENOVA, KAZAKH MINISTER OF HEALTHCARE AND SOCIAL DEVELOPMENT:
Our manufacturers work only in Kazakhstan today. They had to undergo clinical trials and all the analytical examination in order to enter the Russian or Belarusian markets. Now, if they are consistent with the international practice they are eligible to participate in the markets of all EAEU member-states. Pharmaceutical manufacturers fully welcome this agreement.
Meanwhile, medicine for the treatment of children with brittle bone disease may become available in the country until the end of next year. Kazakhstan will receive these medications under the EAEU agreement. In the meantime, children suffering from brittle bones disease are treated in Moscow.